Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mokbanggi-tang is a traditional Korean herbal medicine formula used in East Asian traditional medicine. It is primarily investigated and used for the treatment of conditions related to fluid imbalance such as edema, pleural effusion, and heart failure with preserved ejection fraction (HFpEF). Preliminary studies and case reports suggest its potential use as a therapeutic option for HFpEF and pleural effusion in the context of traditional medicine approaches, but there is minimal large-scale clinical trial evidence to support broad pharmaceutical indications at this time. The precise mechanism of action is not established in scientific literature, typical of traditional herbal mixtures; it is postulated to act on fluid regulation pathways, potentially via modulation of diuresis and inflammation by the synergistic activity of its multiple botanical ingredients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mokbanggi-tang.